Skip to main content Back to Top


Busulfan Injection

Products Affected - Description

    • Busulfan intravenous injection, American Regent, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 00517-0920-08

Reason for the Shortage

    • American Regent did not provide a reason for the shortage.
    • Amneal has busulfan injection available.
    • Athenex launched busulfan injection in March 2019.
    • Mylan refuses to provide availability information.
    • Sagent has busulfan injection available.
    • Teva has busulfan injection available.
    • Otsuka has Busulfex available.

Available Products

    • Busulfex intravenous injection, Otsuka America Pharmaceuticals, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 59148-0070-91
    • Busulfan intravenous injection, Amneal, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 70121-1244-07
    • Busulfan intravenous injection, Athenex, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 70860-0216-10
    • Busulfan intravenous injection, Sagent, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 25021-0241-10
    • Busulfan intravenous injection, Teva, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 45963-0640-77

Estimated Resupply Dates

    • American Regent has busulfan 6 mg/mL 10 mL vials available in limited supply.


Updated June 6, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 4, 2019 by Stephen Andrews, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins